↓ Skip to main content

Dove Medical Press

Clinical value of serum human epididymis protein 4 assay in the diagnosis of ovarian cancer: a meta-analysis

Overview of attention for article published in OncoTargets and therapy, July 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

googleplus
1 Google+ user

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
26 Mendeley
Title
Clinical value of serum human epididymis protein 4 assay in the diagnosis of ovarian cancer: a meta-analysis
Published in
OncoTargets and therapy, July 2013
DOI 10.2147/ott.s45681
Pubmed ID
Authors

Zhijun Yang, Chunyin Wei, Zhaoqing Luo, Li Li

Abstract

Human epididymis protein 4 (HE4) has been approved for diagnosing ovarian cancer. The goal of this meta-analysis was to evaluate the clinical value of the serum HE4 in the diagnosis of ovarian cancer.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 4%
Italy 1 4%
Unknown 24 92%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 19%
Other 4 15%
Student > Master 4 15%
Student > Ph. D. Student 3 12%
Professor 2 8%
Other 4 15%
Unknown 4 15%
Readers by discipline Count As %
Medicine and Dentistry 13 50%
Agricultural and Biological Sciences 4 15%
Biochemistry, Genetics and Molecular Biology 2 8%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Psychology 1 4%
Other 1 4%
Unknown 4 15%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 September 2013.
All research outputs
#17,285,668
of 25,373,627 outputs
Outputs from OncoTargets and therapy
#1,146
of 3,016 outputs
Outputs of similar age
#130,885
of 206,704 outputs
Outputs of similar age from OncoTargets and therapy
#18
of 42 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,016 research outputs from this source. They receive a mean Attention Score of 2.9. This one has gotten more attention than average, scoring higher than 52% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 206,704 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 42 others from the same source and published within six weeks on either side of this one. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.